Literature DB >> 24165062

RETIRED: Investigation and management of non-immune fetal hydrops.

Valérie Désilets1, François Audibert.   

Abstract

This document has been archived because it contains outdated information. It should not be consulted for clinical use, but for historical research only. Please visit the journal website for the most recent guidelines.

Entities:  

Keywords:  fetal hydrops; fetal metabolism; fetal therapy; non-immune hydrops fetalis

Mesh：

Year:  2013        PMID： 24165062     DOI： 10.1016/s1701-2163(15)30816-1

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN： 1701-2163


  3 in total

Review 1.  Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia.

Authors:  Isabelle Malhamé; Christy Gandhi; Gofran Tarabulsi; Matthew Esposito; Kristin Lombardi; Antony Chu; Kenneth K Chen
Journal:  Obstet Med       Date:  2018-11-15

2.  Increased nuchal translucency and pregnancy outcomes: experience of Başkent University Ankara Hospital.

Authors:  Nihal Şahin Uysal; Çağrı Gülümser; Zerrin Yılmaz Çelik; Filiz Bilgin Yanık
Journal:  Turk J Obstet Gynecol       Date:  2019-07-03

3.  SIFD as a novel cause of severe fetal hydrops and neonatal anaemia with iron loading and marked extramedullary haemopoiesis.

Authors:  Chris Barton; Sabiha Kausar; Deborah Kerr; Stefania Bitetti; Rob Wynn
Journal:  J Clin Pathol       Date:  2017-10-21       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.